II. Class
- Anticonvulsant
III. Indications: Adjunctive Therapy
- Simple Partial Seizure
- Complex Partial Seizure
- Bipolar Disorder (not FDA approved)
V. Adverse Effects: Other
- Nonconvulsive Status Epilepticus
VI. Precautions
- Adjust dose in hepatic disease
VII. Dose: Adults and children over age 12
- Initial: 4 mg PO qd for first week
- Increase by 4-8 mg increments per day weekly
- Divide daily dose to bid-qid after first week
- Maximum: 56 mg/day divided bid-qid
Images: Related links to external sites (from Bing)
Related Studies
| tiagabine (on 7/13/2016 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| TIAGABINE HCL 2 MG TABLET | Generic | $5.10 each |
| TIAGABINE HCL 4 MG TABLET | Generic | $4.81 each |
| gabitril (on 1/1/2017 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| GABITRIL 12 MG TABLET | $9.63 each | |
| GABITRIL 16 MG TABLET | $12.87 each | |
| GABITRIL 4 MG TABLET | Generic | $4.81 each |
Ontology: tiagabine (C0068897)
| Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
| MSH | C059205 |
| SnomedCT | 108403006, 372485004 |
| LNC | LP19540-1, MTHU010005 |
| English | N-(4,4-di(3-methylthien-2-yl)but-3-enyl)nipecotic acid, tiagabine, tiagabine [Chemical/Ingredient], tiaGABine, TIAGABINE, Tiagabine, Tiagabine (product), Tiagabine (substance) |
| Spanish | tiagabina (producto), tiagabina (sustancia), tiagabina |
Ontology: Gabitril (C0720560)
| Concepts | Pharmacologic Substance (T121) , Organic Chemical (T109) |
| MSH | C059205 |
| English | Gabitril, gabitril |
